GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NanoString Technologies Inc (OTCPK:NSTGQ) » Definitions » Cyclically Adjusted PS Ratio

NanoString Technologies (NanoString Technologies) Cyclically Adjusted PS Ratio : 0.05 (As of May. 03, 2024)


View and export this data going back to 2013. Start your Free Trial

What is NanoString Technologies Cyclically Adjusted PS Ratio?

As of today (2024-05-03), NanoString Technologies's current share price is $0.20. NanoString Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was $4.19. NanoString Technologies's Cyclically Adjusted PS Ratio for today is 0.05.

The historical rank and industry rank for NanoString Technologies's Cyclically Adjusted PS Ratio or its related term are showing as below:

NSTGQ' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.01   Med: 1.9   Max: 12.11
Current: 0.07

During the past years, NanoString Technologies's highest Cyclically Adjusted PS Ratio was 12.11. The lowest was 0.01. And the median was 1.90.

NSTGQ's Cyclically Adjusted PS Ratio is ranked better than
97.89% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.155 vs NSTGQ: 0.07

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

NanoString Technologies's adjusted revenue per share data for the three months ended in Sep. 2023 was $1.008. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $4.19 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


NanoString Technologies Cyclically Adjusted PS Ratio Historical Data

The historical data trend for NanoString Technologies's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoString Technologies Cyclically Adjusted PS Ratio Chart

NanoString Technologies Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 8.09 1.45

NanoString Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.31 1.45 1.76 0.98 0.41

Competitive Comparison of NanoString Technologies's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, NanoString Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NanoString Technologies's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NanoString Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where NanoString Technologies's Cyclically Adjusted PS Ratio falls into.



NanoString Technologies Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

NanoString Technologies's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.20/4.19
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NanoString Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, NanoString Technologies's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=1.008/129.8595*129.8595
=1.008

Current CPI (Sep. 2023) = 129.8595.

NanoString Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 0.692 98.326 0.914
201403 0.517 99.695 0.673
201406 0.602 100.560 0.777
201409 0.681 100.428 0.881
201412 0.857 99.070 1.123
201503 0.633 99.621 0.825
201506 0.694 100.684 0.895
201509 0.808 100.392 1.045
201512 1.143 99.792 1.487
201603 0.747 100.470 0.966
201606 1.143 101.688 1.460
201609 1.205 101.861 1.536
201612 1.194 101.863 1.522
201703 0.837 102.862 1.057
201706 1.526 103.349 1.917
201709 1.070 104.136 1.334
201712 1.387 104.011 1.732
201803 0.906 105.290 1.117
201806 0.971 106.317 1.186
201809 0.974 106.507 1.188
201812 0.972 105.998 1.191
201903 0.877 107.251 1.062
201906 0.863 108.070 1.037
201909 0.860 108.329 1.031
201912 1.026 108.420 1.229
202003 0.719 108.902 0.857
202006 0.598 108.767 0.714
202009 0.836 109.815 0.989
202012 0.834 109.897 0.985
202103 0.708 111.754 0.823
202106 0.748 114.631 0.847
202109 0.815 115.734 0.914
202112 0.929 117.630 1.026
202203 0.676 121.301 0.724
202206 0.694 125.017 0.721
202209 0.635 125.227 0.658
202212 0.738 125.222 0.765
202303 0.763 127.348 0.778
202306 0.932 128.729 0.940
202309 1.008 129.860 1.008

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NanoString Technologies  (OTCPK:NSTGQ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


NanoString Technologies Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of NanoString Technologies's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoString Technologies (NanoString Technologies) Business Description

Traded in Other Exchanges
Address
530 Fairview Avenue North, Seattle, WA, USA, 98109
NanoString Technologies Inc is engaged in the development, manufacturing and commercialization of instruments, consumables, and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its core technology includes proprietary chemistries that enable the labeling and counting of single molecules. The firm uses its technology to develop tools for scientific and clinical research, primarily in the fields of genomics and proteomics. It offers two product platforms such as nCounter Analysis System or nCounter, and GeoMx Digital Spatial Profiler or DSP system both include instruments, related consumables, and software. NanoString Technologies generates revenue from the sale of products and related services and collaborations.
Executives
Jonathan Todd Garland officer: Chief Commercial Officer C/O CYTEK BIOSCIENCES, INC., 47215 LAKEVIEW BOULEVARD, FREMONT CA 94538
K Thomas Bailey officer: Chief Financial Officer 1618 STATION STREET, VANCOUVER A1 V6A 1B6
R Bradley Gray director, officer: President and CEO 530 FAIRVIEW AVENUE NORTH, SUITE 2000, SEATTLE WA 98109
William Young director 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Waite Charles P Jr director, 10 percent owner 11023 NE 116TH STREET, KIRKLAND WA 98034
Gregory Norden director 16640 CHESTERFIELD GROVE DRIVE, SUITE 200, CHESTERFIELD MO 63005
Elisha W Finney director C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Teresa M. Foy director 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Joseph M Beechem officer: SVP, Research & Development 530 FAIRVIEW AVENUE NORTH, SUITE 2000, SEATTLE WA 98109
John D. Gerace officer: Chief Commercial Officer C/O NANOSTRING TECHNOLOGIES, INC., 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Kirk Malloy director 5200 ILLUMINA WAY, SAN DIEGO CA 92122
J. Chad Brown officer: SVP, Sales & Marketing 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Robert Hershberg director 3005 FIRST AVENUE, SEATTLE WA 98121
Janet George director 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Dana E. Rollison director 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109

NanoString Technologies (NanoString Technologies) Headlines